LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
+4.92%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.79B
AUM Growth
-$1.04B
(-27%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-51.31%
Top 10 Holdings %
Top 10 Hldgs %
47.1%
Holding
407
New
129
Increased
35
Reduced
53
Closed
119
Top Buys
| 1 |
General Motors
GM
|
$158M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 3 |
Honeywell
HON
|
$75.5M |
| 4 |
BP
BP
|
$59.7M |
| 5 |
Walt Disney
DIS
|
$45.8M |
Top Sells
| 1 |
Apple
AAPL
|
$437M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$400M |
| 3 |
T-Mobile US
TMUS
|
$180M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$168M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$118M |
Sector Composition
| 1 | Healthcare | 37.2% |
| 2 | Consumer Staples | 12.28% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Utilities | 7.23% |
| 5 | Industrials | 6.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
101
DELISTED
Inozyme Pharma
INZY
| $2.37M | 0.02% |
557,329
-120,000
| -18% | -$511K |
|
102
LifeMD
LFMD
$294M
| $2.37M | 0.02% |
+285,637
| New | +$2.37M |
|
103
Ouster
OUST
$1.59B
| $2.34M | 0.02% |
+304,984
| New | +$2.34M |
|
104
Linde
LIN
$221B
| $2.26M | 0.02% |
5,500
+1,377
| +33% | +$566K |
|
105
Estee Lauder
EL
$32.2B
| $2.25M | 0.02% |
15,410
-13,714
| -47% | -$2.01M |
|
|
ML
106
DELISTED
MoneyLion Inc.
ML
| $2.19M | 0.02% |
+34,936
| New | +$2.19M |
|
107
DraftKings
DKNG
$22.9B
| $2.19M | 0.02% |
+62,103
| New | +$2.19M |
|
108
LPL Financial
LPLA
$28.7B
| $2.02M | 0.02% |
8,887
| – | – |
|
109
Rekor Systems
REKR
$136M
| $1.99M | 0.02% |
+598,900
| New | +$1.99M |
|
110
Atossa Therapeutics
ATOS
$100M
| $1.96M | 0.02% |
2,225,800
| – | – |
|
|
IMGN
111
DELISTED
Immunogen Inc
IMGN
| $1.93M | 0.02% |
+64,930
| New | +$1.93M |
|
112
The RealReal
REAL
$969M
| $1.9M | 0.02% |
+945,614
| New | +$1.9M |
|
113
Rallybio
RLYB
$24.2M
| $1.87M | 0.02% |
783,391
| – | – |
|
|
ALPN
114
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.85M | 0.02% |
+97,200
| New | +$1.85M |
|
115
Citi Trends
CTRN
$313M
| $1.78M | 0.02% |
+62,816
| New | +$1.78M |
|
116
Alto Ingredients
ALTO
$89.8M
| $1.74M | 0.01% |
+653,457
| New | +$1.74M |
|
117
Aemetis
AMTX
$157M
| $1.7M | 0.01% |
+324,796
| New | +$1.7M |
|
118
CytomX Therapeutics
CTMX
$336M
| $1.7M | 0.01% |
1,093,921
-94,304
| -8% | -$146K |
|
119
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $1.66M | 0.01% |
31,700
-49,700
| -61% | -$2.61M |
|
120
Jefferies Financial Group
JEF
$13.3B
| $1.6M | 0.01% |
39,555
-1,663
| -4% | -$67.2K |
|
121
Applied Therapeutics
APLT
$71.3M
| $1.44M | 0.01% |
431,006
+85,106
| +25% | +$285K |
|
122
Post Holdings
POST
$5.97B
| $1.41M | 0.01% |
16,000
| – | – |
|
123
RCM Technologies
RCMT
$198M
| $1.39M | 0.01% |
+48,037
| New | +$1.39M |
|
124
AbbVie
ABBV
$377B
| $1.39M | 0.01% |
+8,993
| New | +$1.39M |
|
125
Charles Schwab
SCHW
$176B
| $1.35M | 0.01% |
19,587
-306,949
| -94% | -$21.1M |
|